Mckesson Corporation
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 33
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0347-2024 | Class II | CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for | February 12, 2024 |
| D-1172-2018 | Class II | Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only | August 14, 2018 |